Skip to content

Heat-sensitive moxibustion for allergic rhinitis on the optimal intervention: a randomized controlled trial

Heat-sensitive moxibustion for allergic rhinitis on the optimal intervention: a randomized controlled trial

Status
Active, not recruiting
Phases
Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2000034009
Enrollment
Unknown
Registered
2020-06-21
Start date
2020-09-01
Completion date
Unknown
Last updated
2020-06-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

allergic rhinitis

Interventions

Sponsors

The Affiliated Hospital with Jiangxi University of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1. Meet the diagnostic criteria for allergic rhinitis; 2. aged 18 to 65 years; 3. Voluntarily participate in the clinical observation and sign the informed consent; 4. Be able to follow the doctor's treatment arrangement and cooperate with the doctor's treatment and follow-up.

Exclusion criteria

Exclusion criteria: 1. Patients with severe cardiovascular and cerebrovascular diseases, liver, kidney, hematopoietic system and other diseases; 2. have other nasal problems, such as chronic rhinitis, sinusitis, nasal polyps, nasal septum deviation, etc.; 3. patients with mental illness, pregnant or lactating women; 4. Merger of patients with respiratory diseases such as asthma and bronchitis; 5. Patients with dizziness, halo moxibustion or rejection of acupuncture and moxibustion.

Design outcomes

Primary

MeasureTime frame
Total effective rate;

Secondary

MeasureTime frame
symptom score;sign score;Rhinitis quality of life questionnaire;Adverse events;

Countries

China

Contacts

Public ContactXiong Jun

The Affiliated Hospital with Jiangxi University of traditional Chinese medicine

xiongjun196071@163.com+86 13970054277

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026